307 related articles for article (PubMed ID: 31207175)
61. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J
Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887
[TBL] [Abstract][Full Text] [Related]
62. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
63. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
[TBL] [Abstract][Full Text] [Related]
64. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
65. KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway.
Guo J; Zhang W; Sun L; Yu H; Wang Y; Feng L; Yang H
Sci Rep; 2023 May; 13(1):7288. PubMed ID: 37142638
[TBL] [Abstract][Full Text] [Related]
66. LncRNA PCGsEM1 Contributes to the Proliferation, Migration and Invasion of Non-small Cell Lung Cancer Cells via acting as a Sponge for miR-152-3p.
Huang J; Lou J; Liu X; Xie Y
Curr Pharm Des; 2021; 27(46):4663-4670. PubMed ID: 34455968
[TBL] [Abstract][Full Text] [Related]
67. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
Wei S; Wang K; Huang X; Zhao Z; Zhao Z
Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
[TBL] [Abstract][Full Text] [Related]
68. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL
J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070
[TBL] [Abstract][Full Text] [Related]
69. LINC00324 exerts tumor-promoting functions in lung adenocarcinoma via targeting miR-615-5p/AKT1 axis.
Pan ZH; Guo XQ; Shan J; Luo SX
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8333-8342. PubMed ID: 30556874
[TBL] [Abstract][Full Text] [Related]
70. LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis.
Liu Y; Li L; Shang P; Song X
Anticancer Drugs; 2020 Nov; 31(10):1065-1073. PubMed ID: 32649368
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
72. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
73. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.
Liu C; Yang H; Xu Z; Li D; Zhou M; Xiao K; Shi Z; Zhu L; Yang L; Zhou R
J Cancer Res Clin Oncol; 2015 Mar; 141(3):431-41. PubMed ID: 25245053
[TBL] [Abstract][Full Text] [Related]
74. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p.
Yang S; Liu T; Sun Y; Liang X
Cell Mol Biol Lett; 2019; 24():70. PubMed ID: 31889958
[TBL] [Abstract][Full Text] [Related]
75. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of miR-144-3p exacerbates non-small cell lung cancer progression by targeting CEP55.
Li M; Liu Y; Jiang X; Hang Y; Wang H; Liu H; Chen Z; Xiao Y
Acta Biochim Biophys Sin (Shanghai); 2021 Oct; 53(10):1398-1407. PubMed ID: 34435195
[TBL] [Abstract][Full Text] [Related]
77. LncRNA NORAD promotes the progression of myocardial infarction by targeting the miR-22-3p/PTEN axis.
Li C; Zhang L; Bu X; Chu G; Zhao X; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):463-473. PubMed ID: 35607965
[TBL] [Abstract][Full Text] [Related]
78. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1.
Cheng G; Li Y; Liu Z; Song X
Adv Clin Exp Med; 2021 Oct; 30(10):1043-1050. PubMed ID: 34610219
[TBL] [Abstract][Full Text] [Related]
79. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
80. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
